Cargando…

Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients

Histone deacetylases modulate the dynamic balance of histone acetylation and deacetylation in cells, which participate in epigenetic regulations. Accumulated evidence has demonstrated that histone deacetylases are associated with angiogenesis, cell proliferation and survival in a variety of human ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lulu, Xu, Xiaohui, Liu, Hailing, Hu, Xiaoli, Zhang, Wenwen, Ye, Miaomiao, Zhu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277648/ https://www.ncbi.nlm.nih.gov/pubmed/30519361 http://dx.doi.org/10.7150/jca.26780

Ejemplares similares

Prognostic values of aquaporins mRNA expression in human ovarian cancer
por: Chetry, Mandika, et al.
Publicado: (2018)

Association of histone deacetylase expression with histology and prognosis of ovarian cancer
por: Yano, Mitsutake, et al.
Publicado: (2018)

Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway
por: Zhang, Wenwen, et al.
Publicado: (2020)

Prognostic value of microvessel density in cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2018)

The prognostic values of the peroxiredoxins family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2018)

Histone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilization
por: Wang, Hao, et al.
Publicado: (2016)

Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells
por: Chatterjee, Namita, et al.
Publicado: (2013)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3
por: Pufahl, Laura, et al.
Publicado: (2012)

Atrogin-1/MAFbx mRNA expression is regulated by histone deacetylase 1 in rat soleus muscle under hindlimb unloading
por: Mochalova, Ekaterina P., et al.
Publicado: (2019)

Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues
por: GU, YIFENG, et al.
Publicado: (2013)

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
por: Takai, Noriyuki, et al.
Publicado: (2010)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
por: Guo, Fengyi, et al.
Publicado: (2022)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
por: Xu, Long, et al.
Publicado: (2023)

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
por: Wang, Wenwen, et al.
Publicado: (2021)

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells
por: Weberpals, Johanne I, et al.
Publicado: (2011)

The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies
por: Luo, Hui, et al.
Publicado: (2018)

Concentrating pre-mRNA processing factors in the histone locus body facilitates efficient histone mRNA biogenesis
por: Tatomer, Deirdre C., et al.
Publicado: (2016)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

Effects of dynein light chain Tctex-type 3 on the biological behavior of ovarian cancer
por: Zhou, Lulu, et al.
Publicado: (2019)

The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy
por: Cao, Lin-Lin, et al.
Publicado: (2017)

Histone gene expression and histone mRNA 3' end structure in Caenorhabditis elegans
por: Keall, Rebecca, et al.
Publicado: (2007)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis
por: Zhu, Haiyan, et al.
Publicado: (2016)

Human histone pre-mRNA assembles histone or canonical mRNA-processing complexes by overlapping 3′-end sequence elements
por: Ielasi, Francesco S, et al.
Publicado: (2022)

The Role of Histone Acetyltransferases and Histone Deacetylases in Photoreceptor Differentiation and Degeneration
por: Zhao, Meng, et al.
Publicado: (2020)

Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation
por: Angiolilli, Chiara, et al.
Publicado: (2018)

Prognostic values of transketolase family genes in ovarian cancer
por: Zhao, Menghuang, et al.
Publicado: (2019)

Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
por: Hu, Zhicheng, et al.
Publicado: (2020)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
por: Huang, Ying, et al.
Publicado: (2011)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
por: Ding, Ning, et al.
Publicado: (2014)

mRNA Levels of Related Abcb Genes Change Opposite to Each Other upon Histone Deacetylase Inhibition in Drug-Resistant Rat Hepatoma Cells
por: Sike, Ádám, et al.
Publicado: (2014)

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy
por: Peper, Janet Kerstin, et al.
Publicado: (2015)

Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
por: Pramanik, Siddhartha Das, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tsqs8nq1m2m3ibh28pm8he25r